Mirzotamab is an IgG1kappa antibody targeting to CD276/B7-H3. Mirzotamab can conjugates with Clezutoclaxum is a targeted antibody drug conjugate (ADC).
CAS Number:
[2229859-11-2]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted